Long-Term Follow-Up of Patients with Scleritis After Rituximab Treatment Including B Cell Monitoring.
van Bilsen K, Vergouwen DPC, van Velthoven MEJ, Missotten TOAR, Rombach SM, van Zelm MC, Berkowska MA, van Hagen PM, Kuijpers RWAM, van Laar JAM.
van Bilsen K, et al. Among authors: kuijpers rwam.
Ocul Immunol Inflamm. 2023 Jul 12:1-6. doi: 10.1080/09273948.2023.2229900. Online ahead of print.
Ocul Immunol Inflamm. 2023.
PMID: 37437135